Clostridium difficile Infections
Clostridium difficile Infections
Explore linked clinical trials. Standard reference: MESH:M00062225127 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections | Recruiting | Phase 2 | 2026-10-07 | NCT07285213 | |
| LMN-201 for Prevention of C. Difficile Infection Recurrence | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections | Active, not recruiting | Phase 2 / Phase 3 | 2026-10-05 | NCT05330182 | |
| VE303 for Prevention of Recurrent Clostridioides Difficile Infection | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium difficile colitis, Clostridium infectious disease, Digestive System Diseases, Infections, bacterial infectious disease, central diabetes insipidus, digestive system disorder, dysentery, gastroenteritis, gram-positive bacterial infections, intestinal disorder | Recruiting | Phase 3 | 2026-09-29 | NCT06237452 | |
| Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Recurrent Infection, Reinfection, bacterial infectious disease, gram-positive bacterial infections | Recruiting | Phase 1 / Phase 2 | 2026-09-23 | NCT06306014 | |
| Safety Registry of a Fecal Microbiota Transplant Cohort | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections | Recruiting | Not stated | 2026-08-18 | NCT06311006 | |
| Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections | Recruiting | Phase 3 | 2026-07-10 | NCT05266807 | |
| Lifestyle and Recurrent Clostridioides Difficile Infection (CDI) | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections | Recruiting | Not applicable | 2026-07-08 | NCT07613645 | |
| Secondary Prevention of Clostridioides Difficile Using Vancomycin | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, bacterial infectious disease, gram-positive bacterial infections | Recruiting | Phase 2 / Phase 3 | 2026-06-24 | NCT06979609 | |
| Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Digestive System Diseases, Infections, bacterial infectious disease, colitis, colonic disorder, digestive system disorder, gastroenteritis, gram-positive bacterial infections, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 1 | 2026-06-04 | NCT07401680 | |
| Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only Treatment | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections | Not yet recruiting | Not stated | 2026-05-06 | NCT07569380 | |
| Evaluation of GeoHAI Implementation | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bacterial infectious disease, gram-positive bacterial infections, iatrogenic disease, nosocomial infection | Active, not recruiting | Not applicable | 2026-05-05 | NCT05612672 | |
| Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections | Not yet recruiting | Early phase 1 | 2026-04-29 | NCT06884748 | |
| Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial Clearance | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections | Recruiting | Not stated | 2026-03-02 | NCT06030245 | |
| Xylitol Use for Decolonization of C. Difficile in Patients With IBD | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Crohn disease, Digestive System Diseases, Infections, bacterial infectious disease, colitis, colonic disorder, digestive system disorder, gastroenteritis, gram-positive bacterial infections, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 1 | 2026-02-25 | NCT05852587 | |
| Clostridioides Difficile: Understanding Responses and Treatment Effects | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Dysbiosis, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bacterial infectious disease, gram-positive bacterial infections | Recruiting | Not stated | 2026-01-28 | NCT07374094 | |
| Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Digestive System Diseases, Infections, bacterial infectious disease, digestive system disorder, gastroenteritis, gram-positive bacterial infections, inflammatory bowel disease, intestinal disorder | Not yet recruiting | Early phase 1 | 2025-12-16 | NCT06799039 | |
| Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Digestive System Diseases, Infections, bacterial infectious disease, colitis, colonic disorder, digestive system disorder, gastroenteritis, gram-positive bacterial infections, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 4 | 2025-11-03 | NCT06794944 | |
| STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Reinfection, bacterial infectious disease, gram-positive bacterial infections | Not yet recruiting | Not applicable | 2025-08-13 | NCT07120490 | |
| A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections. | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Digestive System Diseases, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, bacterial infectious disease, colonic disorder, digestive system disorder, functional colonic disease, gram-positive bacterial infections, intestinal disorder, irritable bowel syndrome | Not yet recruiting | Phase 2 | 2025-04-29 | NCT06948461 | |
| FMT in Initial CDI | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections | Recruiting | Not applicable | 2025-04-11 | NCT05257538 | |
| Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain in Nephrology and Transplantation Department | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections | Recruiting | Not applicable | 2025-03-05 | NCT06859437 | |
| CMTS0929 for Clostridioides Difficile Infection | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections | Not yet recruiting | Early phase 1 | 2025-02-20 | NCT06836427 | |
| Study of Clostridioides Difficile in Infants | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections | Recruiting | Not stated | 2025-01-23 | NCT06788769 | |
| Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT) | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium difficile colitis, Clostridium infectious disease, Digestive System Diseases, Infections, bacterial infectious disease, digestive system disorder, enterocolitis, gastroenteritis, gram-positive bacterial infections, intestinal disorder | Recruiting | Phase 2 | 2024-10-26 | NCT04305769 | |
| Virus as Treatment of C. Difficile Infection (VISION) | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections | Not yet recruiting | Not applicable | 2024-05-03 | NCT06398379 |